Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3. - van Meerten T; Kersten MJ; Iacoboni G; Hess G; Mutsaers P; García-Sancho AM; Goy A; Giné E; Hill BT; Weng WK; Reagan PM; Patel K; et al. (Blood, 2026)